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Abstract 
Hypertension is a risk factor for dementia, but its exact role in contributing to 
dementia remains unknown. We conducted a community-based retrospective cohort 
study to examine the association of hypertension and widened pulse pressure (PP) with 
incident significant cognitive impairment (SCI) in the Chinese older people in Hong 
Kong. A total of 1925 subjects who were 65 years and older, ethnic Chinese, and 
community-living, with no history of cerebrovascular accidents or dementia, were 
recruited. Demographics, medical history, and physical parameters recorded at 
baseline were retrieved for analysis. Primary outcome was SCI developed in 6 years, 
which was defined by the presence of clinical dementia, scoring below the cutoff point 
on the Cantonese version of the Mini-Mental State Examination, and/or a global 
Clinical Dementia Rating of 1 to 3. Our data showed no difference in the point 
prevalence of pre-existing hypertension between subjects who remained cognitively 
stable and those who developed SCI (64.2% versus 65.8%; χ2 test, p=0.68). However, 
subjects with incident SCI had a higher baseline PP (70mmHg versus 66mmHg; 
Mann-Whitney U-test, p=0.03) and a decreasing trend in PP with time. Multiple 
logistic regression analysis showed that PP had a small but significant effect on the 
risk of SCI among the younger old subjects (OR=1.02, p=0.03).  Our findings 
suggested that widened PP might be a risk factor for SCI among the younger old 
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people. Further studies are needed to ascertain the association between hypertension 
and SCI in the Chinese older population and how widened PP contributes to SCI. 
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Introduction 
 Dementia is a syndrome characterized by progressive global cognitive decline, 
resulting in an appreciable deterioration in intellectual functioning and interference 
with personal activities of daily living [1]. In view of the limitations in modifying the 
disease burden, current research focuses on the identification of risk factors to prevent 
or delay the onset of cognitive decline. Age, genetic predispositions, and 
cerebrovascular diseases are recognized risk factors for Alzheimer's disease and 
vascular dementia [2, 3]. Vascular risk factors, in particular hypertension, however, 
have a less straightforward association with cognitive impairment. Longitudinal 
population-based studies suggested that mid-life hypertension increased the risk of 
late-life cognitive impairment [4, 5], whereas hypertension and hypotension at late life 
were associated with cognitive impairment [6, 7]. Nevertheless, the underlying 
mechanism of how hypertension at different stages of life affects cognition is not well 
understood [8], and it remains controversial whether systolic or diastolic hypertension 
plays a more important role in the development of cognitive impairment [9]. 
Furthermore, the target blood pressure (BP) for a cognitively beneficial effect has yet 
to be determined [10].  Convincing evidence supporting that anti-hypertensive 
treatment can lower the risk of dementia and cognitive impairment in patients with no 
known cerebrovascular disease is still lacking [11]. Hence, further studies examining 
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the relationship between hypertension and dementia are much needed. 
 Apart from systolic blood pressure (SBP) and diastolic blood pressure (DBP), a 
major component of BP is the pulse pressure (PP), which is the difference between 
SBP and DBP. PP is a surrogate measure of the arterial stiffness. Prospective 
population-based studies of heart diseases suggested that the higher the PP a person 
had, the greater the chance of developing cardiovascular events [12, 13]. However, 
there has been no consensus as to the normal range of PP for different age groups 
despite PP is known to change with age. In early mid-life, SBP and DBP increase in 
parallel, so PP remains relatively stable. In late mid-life, SBP continues to increase 
while DBP starts to level off or even decline because of arterial stiffness, causing PP to 
increase progressively with time [14]. Several recent studies have suggested that a 
higher PP is associated with late-life cognitive impairment [15–17], and arterial 
stiffness is believed to play an important role in the development of cognitive 
impairment and dementia [18, 19]. However, the longitudinal trend of PP in older 
people with dementia, which is likely to be different from that in people with normal 
cognition because both SBP and DBP are noted to decrease a few years prior to the 
onset and during the course of dementia [20, 21], is not well studied. Hence, additional 
studies are needed to determine if PP may be used as a predictor for dementia among 
the older people. 
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 In Hong Kong, majority of the population is ethnic Chinese, and the proportion of 
older people suffering from cognitive impairments is similar to that of the mainland 
counterparts [22–25]. Although the prevalence of mid-life hypertension is comparable 
with that of developed countries, the prevalence of late-life hypertension is much 
higher, with 66.3% of people aged 65 to 74 years in Hong Kong having hypertension 
[26] comparing to 53% in the North American countries [27]. Given the differences in 
the prevalence of hypertension and the population demographics between the Chinese 
and the Caucasian communities, it would be of interest to find out whether 
hypertension is also an independent risk factor for cognitive impairment among the 
Hong Kong Chinese older people and whether PP can be predictive of cognitive 
impairment in the Chinese older population.  
In this retrospective cohort study, we aimed to examine if hypertension and PP 
were associated with development of significant cognitive impairment (SCI) in 
community-living Chinese older people over a 6-year period. The findings may 
provide some additional insight into how PP, a potential proxy marker for arterial 
health, contributes to the development of cognitive impairment in later life.  
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Methods 
Participants: 
 Participants in this community-based retrospective cohort study were drawn from 
all the people who attended the Elderly Health Centre (EHC) in Nam Shan district 
(one of the 18 EHCs in Hong Kong) in 2005. The EHCs were set up by the Elderly 
Health Services (EHS) of the Department of Health of the Government of Hong Kong 
Special Administrative Region (HKSAR) in 1998. With one EHC established in every 
district of Hong Kong, these public walk-in clinics provide annual primary health care 
for the interested local residents aged 65 years and above. In 2005, 37620 older people 
aged 65 years and above attended EHCs in Hong Kong for clinical and cognitive 
assessment.  
Eligibility requirements for this study included subjects who were 65 years and 
older, ethnic Chinese, and community dwelling, with no known history of 
cerebrovascular accidents or dementia when they attended the Nam Shan EHC in 2005. 
Subjects who were living in old-aged homes, had history of cerebrovascular accidents, 
and/or had SCI as defined by presence of clinical dementia or scoring below the cutoff 
point on the Cantonese version of the Mini-Mental State Examination (C-MMSE) – 18 
or below for illiterate subjects, 20 or below for those having 1 to 2 years of education, 
and 22 or below for those with more than 2 years of education [28] – were excluded.  
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Clinical assessment: 
 At baseline and in the annual re-assessments, subjects were interviewed at EHC 
by trained nurses and doctors using questionnaires covering demographics and 
medical history including hypertension, diabetes mellitus (DM), hypercholesterolemia, 
heart disease, cerebrovascular disease, dementia, smoking and drinking pattern, and 
depression. In addition, physical parameters such as body weight, body height and 
body mass index (BMI), BP, and fasting total cholesterol level were measured. 
Glycated hemoglobin (HbA1c) was also measured for subjects who had DM.  
 
BP measurement: 
 Brachial BP was measured with an electronic sphygmomanometer using an 
appropriately sized cuff after the subject sat at rest for at least 5 minutes. Subjects with 
SBP ≥140mmHg and/or DBP ≥90mmHg would have their BP rechecked again after 
resting for another 5 minutes, and the average of the two BP readings would be used 
for analysis. Subjects with average SBP ≥140mmHg or average DBP ≥90mmHg were 
defined as having hypertension. PP was measured by subtracting DBP from SBP.  
 
Cognitive assessment: 
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 Cognitive status was examined by the EHC staff at baseline and in the annual 
re-assessments. The Simplified Memory Test (SMT), which was equivalent to the 
3-object delayed recall test, was used to screen for any significant memory problem 
among subjects who had no known history of dementia or no report of memory 
impairment. C-MMSE was performed on subjects who failed to score full marks in 
SMT, had history of dementia, complained of memory decline, or were noticed by 
others to have memory problem. Subjects who did not attend EHC for re-assessment 
were traced by the research assistants, and C-MMSE and Clinical Dementia Rating 
(CDR) were used to evaluate their cognitive function. CDR is a semi-structured 
interview and evaluates six domains of cognitive and functional performance, namely 
memory, orientation, judgment, community affairs, home and hobbies, and personal 
care. The scoring is based on the information collected from the subjects and their 
informants and the clinical judgment of the rater [29]. A global CDR of 0, 0.5, 1, 2, 
and 3 is given to subjects who have no dementia, very mild dementia, mild dementia, 
moderate dementia, and severe dementia, respectively. CDR has been widely used as a 
clinical staging tool for dementia, including in the Asian populations where its validity 
and reliability had been published elsewhere [30]. In this study, the inter-rater 
reliability of CDR among the research team members, measured by the intraclass 
correlation, was 0.86. 
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Data collection for follow-up assessments: 
 For participants who attended at least two follow-up assessments at any EHC 
between 2006 and 2011, with at least one assessment since 2008, anonymized data 
were retrieved from the database of EHS for group analyses. For participants who had 
less than two assessments at EHCs since 2006 or had no follow-up since 2008, active 
tracing was performed. EHS would first crosscheck the subjects’ names with the 
Deaths Registries of the Government of HKSAR. For subjects not identified in the 
Deaths Registries, postal and/or phone contacts were made for invitation of follow-up. 
Subjects who agreed for assessment were interviewed at EHC or at home by trained 
research assistants and geriatric psychiatrists. Informed consent was obtained from 
each subject before the assessment was started. In the occasional situation when the 
subjects were mentally incapable in giving consent for assessment, consent from their 
relatives was sought. In this study, tracing and assessment of the defaulted subjects 
was conducted from October 2011 to February 2012. Clinical interview, measurement 
of physical parameters, and cognitive assessment were performed by the research team 
in the same way as done by the EHC staff, with the exception of using CDR as an 
additional tool of outcome measurement. In some occasions when the defaulted 
subjects agreed for phone interview only, assessment of cognition using CDR and 
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enquiry of medical history were conducted over the phone. 
 
Primary outcome: 
 The primary outcome in this study was incident SCI, which was defined by the 
presence of dementia in accordance with the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) [31], scoring below 
the cutoff point on C-MMSE, and a global CDR of 1–3. 
 
Sample size estimation: 
 The sample size estimation was performed using the Power and Precision 
software version 3.0 (Biostat, Englewood, New Jersey, USA). Sample size was 
obtained from estimates of conversion rate of SCI and previous estimate of major risks 
for dementia in Hong Kong. Given that the participants at EHC were 
community-dwelling older people with no clinical dementia at baseline, an estimate of 
6% incidence for SCI over a 6-year period was adopted [32]. For sample size estimates 
from computation of significant predictors, 48% of the variance for dementia 
diagnosis could be explained by gender, age, education, exercise participation and 
significant cerebrovascular risks [22]. With covariates of age and education estimated 
as significant variables, for 100 cases of SCI identified, the power for estimation of 
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risk factors would be 80% power (α=0.05). A baseline sample of 2,000 participants 
would yield adequate power for detection of cognitive outcomes at follow-up. 
 
Statistical analyses: 
 All other analyses were performed using the Statistical Package for Social 
Sciences (SPSS) software version 17.0 (SPSS, Chicago, Illinois, USA). Normality of 
the data distribution, which was found to be positively skewed in this study, was 
assessed with the Kolmogorov-Smirnov test. The prevalence of hypertension of our 
sample was compared with that of the general older population using the one-sample 
t-test. Comparison of baseline continuous and categorical variables between the two 
groups (subjects who remained cognitively stable and those who developed SCI in 6 
years) was analyzed with the Mann-Whitney U-test and the Chi-squared (χ2) test, 
respectively. To examine if late-onset vascular risk factors (hypertension, DM, 
hypercholesterolemia, heart disease, and CVA) were associated with incident SCI, 
subjects who had no vascular risk factors at baseline but were diagnosed with vascular 
risk factors during the follow-up period prior to the development of SCI were selected, 
and χ2 test was used for analysis. The level of statistical significance was set at p<0.05. 
To determine if widened PP and other factors at baseline were risk factors for SCI, 
variables with statistical significance of p<0.1 were selected as potential confounders 
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and entered into the multiple logistic regression model. The odds ratios (ORs) were 
computed to yield point estimates with a 95% confidence interval (CI). To look for any 
changes in PP with time, subjects who had re-assessment in both 2008 and 2011 were 
selected, and the median PP in 2005, 2008, and 2011 were compared with one another 
in pairs using the Wilcoxon test. Using the Bonferroni correction, the cutoff for 
statistical significance for the longitudinal changes in median PP was set at p<0.01. 
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Results 
Baseline characteristics: 
 A total of 2071 subjects attended EHC in 2005. The prevalence of hypertension 
of these subjects (65.2%) was lower than that of the general older population in Hong 
Kong (68.8%) [26] (p<0.001). 146 (7.0%) subjects were excluded from this study 
because they were living in old-aged homes, were not ethnic Chinese, had history of 
cerebrovascular accidents, and/or had already had SCI (Figure 1). Therefore, 1925 
(93.0%) subjects were recruited into our study. 
Among the recruited subjects, 1453 (75.5%) attended at least two annual 
assessments at EHCs since 2006, with at least one assessment since 2008. On average, 
they visited EHCs 3.4 times for re-assessment in the 6-year study period. The 
remaining 472 (24.5%) subjects had less than two assessments at EHCs since 2006 or 
defaulted follow-up since 2008. They were older (p<0.001), had a higher prevalence of 
hypertension and heart diseases (p<0.001), had a lower prevalence of 
hypercholesterolemia (p<0.001), and had a lower BMI (p=0.01) at baseline comparing 
with those who had regular follow-up (Table 1). 
Among the defaulted subjects, 143 were dead, leaving 329 for active tracing: 159 
subjects were interviewed by the research team; 2 subjects attended EHC by 
themselves after they were traced by the research team; 5 were confirmed to be dead; 
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and the rest declined for interview or could not be traced. This made up a total of 1614 
(83.8%) subjects having at least one assessment since 2008. 
 
Incident SCI: 
 A total of 161 (8.4%) subjects developed SCI in the 6-year study period. The 
proportion of subjects developing SCI increased with advancing age (Table 2). Table 3 
showed the differences in demographic characteristics and baseline cardiovascular risk 
factors between subjects who remained cognitively stable and those who developed 
SCI. Subjects with incident SCI were older (p<0.001) and had lower education 
attainment (p=0.06). No significant difference in the point prevalence of DM, 
hypercholesterolemia, heart disease, obesity, smoking, alcohol use, and depression at 
baseline was noted between the two groups.  
 
Association between hypertension and SCI 
 1239 (64.4%) subjects had history of hypertension at baseline. However, there 
was no statistically significant difference in the point prevalence of pre-existing 
hypertension between subjects who remained cognitively stable and those who 
developed SCI (64.2% versus 65.8%; χ2 test, p=0.68; Table 3). 
Baseline SBP appeared to be slightly higher among subjects who developed SCI 
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compared to those who did not, but the difference was not statistically significant 
(140mmHg versus 138mmHg; Mann-Whitney U-test, p=0.10; Table 3). There was no 
difference in baseline DBP between the two groups. 
 
Association between PP and SCI 
Baseline PP was higher among subjects who developed SCI compared to those 
who remained cognitively stable (70mmHg versus 66mmHg; Mann-Whitney U-test, 
p=0.03; Table 3). Although PP was the only vascular risk factor at baseline that was 
associated with incident SCI, it might be related to an underlying cardiovascular or 
cerebrovascular disease which predisposed to SCI. Therefore, the association between 
late-life vascular risk factors and incident SCI was examined by excluding subjects 
with known vascular risks at baseline and those who developed SCI before vascular 
risk factors emerged during the follow-up period. Hypertension, hypercholesterolemia, 
heart disease, and CVA that were newly developed during the follow-up period all had 
no association with incident SCI. The association between late-onset DM and incident 
SCI could not be ascertained in this study due to the limited number of subjects 
suffering from late-life DM and SCI. 
 Since a higher baseline PP was found to be associated with incident SCI, multiple 
logistic regression analysis was performed to assess the association between PP and 
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other potential confounders, including age, literacy, and SBP. As shown in Table 4, age 
was the only variable remained to be statistically significant in the regression model 
(OR = 1.07, 95% CI: 1.04–1.11, p<0.001). 
 To study the effect of age on the association between PP and SCI, multiple 
logistic regression was repeated with the exception of using age as a categorical 
variable with cutoff at 70, 75, and 80 years old. As illustrated in Table 5, PP had a 
small but significant effect on the risk of SCI in the younger old subjects (OR = 1.02, 
95% CI: 1.00–1.05, p=0.03). The effect of age on the risk of SCI was not statistically 
significant until age reached 75 and above (OR = 1.89–2.19, p<0.001).  
 To determine if PP changed with time, Wilcoxon test was used to look for any 
difference in the median PP between 2005 and 2008, 2008 and 2011, and 2005 and 
2011. A total of 627 subjects who remained cognitively stable and 53 subjects who had 
incident SCI had re-assessment in 2008 and 2011. As shown in Table 6, PP increased 
with time among subjects who remained cognitively stable (64.5mmHg in 2005, 
68.0mmHg in 2008, and 70.0mmHg in 2011; Bonferroni correction, p<0.01), but not 
among subjects with incident SCI (74.0mmHg in 2005, 70.0mmHg in 2008, and 
69.0mmHg in 2011; Bonferroni correction, p>0.01). 
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Discussion 
 Our present study did not find an association between pre-existing hypertension 
and incident SCI in the Chinese older people. This is apparently inconsistent with the 
results of the western epidemiologic studies which highlighted an association between 
hypertension and cognitive impairment. There are several possible explanations for the 
difference in findings. First, hypertension is highly prevalent among the Hong Kong 
Chinese, so it may be difficult to find a statistically significant difference in the point 
prevalence of hypertension between the two groups. Second, the association between 
hypertension and cognitive impairment is dependent on the age of onset of 
hypertension. In this study, we could not examine whether hypertension at mid-life or 
late-life, or both, was associated with incident SCI because all our subjects were at 
least 65 years old at baseline and we did not have information on their age of onset of 
hypertension. Third, our sample might represent only the mild to moderate cases of 
hypertension, as older people with moderate to severe hypertension were likely 
receiving treatment in the medical specialist out-patient clinics instead. Last, subjects 
with hypertension might have already received anti-hypertensive treatment. Indeed, 
both groups of subjects had relatively normal SBP and normal DBP at baseline despite 
having high point prevalence of pre-existing hypertension. The treatment effect would 
bias towards the null hypothesis and thus underestimate the power of hypertension in 
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predicting the risk of SCI as suggested by a previous study [4]. Further studies are 
needed to ascertain whether the degree of BP control influences the association 
between hypertension and SCI in the local older population. 
 Another interesting finding of this study is that widened PP is associated with the 
development of SCI in the Chinese older people. Since age influences both BP and 
cognition, it might be a confounding factor in the association between PP and SCI. Our 
results showed that after controlling for factors including age, PP still had a small but 
significant effect on the risk of SCI among the younger old Chinese. Hence, younger 
old people with widened PP may be at risk of developing cognitive impairment in their 
later life. Since PP is a surrogate measure of the arterial compliance, several 
mechanisms might explain how widened PP is involved in the development of SCI. 
First, increased stiffness of the arterial wall might lead to narrowing of vessel lumen, 
reduction of cerebral perfusion, and greater susceptibility of hypoxia and ischemia 
[21]. Second, the resultant hypoxia might induce upregulation of the β-site amyloid 
precursor protein-cleaving enzyme 1 (BACE1) gene and increase the production of 
amyloid-β plaques [33, 34]. Third, the loss of damping due to increased arterial 
stiffness might increase the transmission of pulse wave towards the distal blood 
vessels, making the brain tissues more susceptible to direct injury [16]. Last, 
diminished arterial compliance might reflect diffuse atherosclerosis, which was 
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implicated in the development of dementia [35, 36]. Further studies are required to 
ascertain the underlying pathogenic mechanisms of widened PP in cognitive 
impairment in the older population. 
We found that PP continued to increase with time in subjects who remained 
cognitively stable, whereas a decreasing trend in PP was observed among those with 
incident SCI. This observation is consistent with the current understanding that PP 
increases progressively with time among older people with no dementia, whereas both 
SBP and DBP decrease in the years prior to the onset and during the course of 
dementia [14, 20, 21]. The difference in the trajectories of PP between subjects who 
remained cognitively stable and those who developed SCI is of potential clinical 
significance. Since widened PP is suggestive of arterial stiffness, we speculate that 
older people with a high PP but not yet cognitively impaired may be at the stage when 
compensatory mechanisms are still functioning, so the cerebral autoregulation remains 
relatively effective in keeping an optimal blood flow in the brain [37]. This may help 
explain why higher PP has been observed to be associated with better cognition in 
some older people [38]. However, once the compensatory mechanisms are lost, the 
older people may become predisposed to cerebral arterial insufficiency, which leads to 
ischemia, hypoxia, and direct injury of the brain tissues as described above and 
thereby results in SCI. The loss of baroreflex function observed in patients with 
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Alzheimer’s disease may further aggravate the cognitive decline [39]. Hence, a 
widened PP may be a useful clinical marker for late-life SCI. 
Although our study showed that PP might be a risk factor for SCI among the 
younger old Chinese, there were a few potential limitations and precautions in using 
PP as a predictor of SCI. First, because of the dynamic and age-dependent changes of 
BP, measuring BP (and thereby calculating PP) on a single occasion might not 
accurately reflect the BP profile of an individual. Ambulatory BP monitoring is an 
alternative method which allows BP to be recorded over a longer period of time, but it 
is impractical for population-based studies. Hence, taking the average of several BP 
readings that are measured in different occasions remains to be a reasonably good 
option in measuring PP. Second, instead of measuring the central PP, the use of 
sphygmomanometer at brachial artery allows measurement of the peripheral PP only. 
Because of the amplification of PP between central and peripheral arteries, there is a 
high peripheral-to-central PP gradient in healthy adults [40]. Nevertheless, since the 
compliance of arteries decreases with age, such gradient is often lost in the older 
people, thus making the peripheral and central PP being similar. Therefore, the 
peripheral PP measured at the brachial artery using the cuff technique can still provide 
a fairly good estimation of the central PP among the older people. Third, although 
pulse wave velocity (PWV) measured by transcutaneous Doppler has been proposed to 
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be a better alternative to PP in assessing the arterial stiffness, similar outcomes have 
been reported when studying the association between cognitive decline and arterial 
stiffness with either method [16]. Therefore, PP appears to be reliable in estimating the 
degree of arterial compliance. Last, PP can be affected by various factors such as 
aortic regurgitation and congestive heart failure [41]. The reason is that apart from 
being a function of the arterial compliance, PP is partly dependent on the stroke 
volume. Therefore, subjects with aortic regurgitation might have a higher PP, whereas 
those suffering from congestive heart failure might have a lower PP. Certain types of 
anti-hypertensive medication might also influence PP [42]. In this study, we did not 
have detailed information about the type of heart problems or the class of 
anti-hypertensive medications our subjects had been having at baseline. Nevertheless, 
there was no significant difference in the proportion of subjects who suffered from 
pre-existing heart diseases between the two groups. It would be of interest to study if 
different types of heart diseases or anti-hypertensive medications would influence the 
association between PP and SCI in the Chinese older people. 
 There are a number of methodological limitations to the current study. First, 
although follow-up data were available for 83.8% subjects, the remaining ones who 
could not be interviewed might be cognitively impaired as the defaulted subjects had 
more co-morbidities comparing to those who had regular follow-up. Therefore, the 
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number of subjects with incident SCI might be underestimated. Second, as mentioned 
above, it is best to measure BP by taking the average of several BP readings that are 
measured in different occasions. In our study, subjects with normal BP were not 
required to have a second reading due to logistic reason at EHC. Only subjects with 
SBP ≥140mmHg and/or DBP ≥90mmHg had their BP rechecked. Third, due to the 
restraint in time and resources, comprehensive cognitive assessments were not feasible 
in the daily clinical practice at EHC. The use of SMT as a screening tool for cognitive 
impairment might not be sensitive enough to identify subjects who had mild dementia. 
Also, C-MMSE could not substitute a formal cognitive assessment in diagnosing 
dementia. To improve detection rate and diagnostic certainty of SCI, we adopted CDR 
to help identify defaulted subjects who had cognitive impairment at follow-up. Last, 
collection of medical history was based on the subjects’ or their informants’ 
self-reporting information, which would have introduced recall bias.  
In spite of the limitations, our study had several strengths. The demographic 
characteristics and the point prevalence of the baseline cardiovascular risk factors of 
our sample were representative of the community-living Chinese older people in Hong 
Kong [26]. Our present findings may therefore be more robust among the general 
healthy older population. Also, our study included a relatively long follow-up period 
and a sufficiently large sample size. In addition, we managed to identify the latest 
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cognitive status of the majority of the sample, and we took into consideration of 
various potential confounders when studying the association between hypertension and 
SCI. 
 With widened PP being a potential risk factor for SCI and not simply being a 
function of age, it adds to the predictive value of the currently known risk factors for 
cognitive impairment among the younger old people. Since measuring PP is simple, 
inexpensive, and easily accessible without any risk involved, it brings great clinical 
and public health implication. First, measuring PP can be included as part of the 
assessment in the population screening for dementia as it can help identify people that 
are at risk of cognitive impairment. Second, widened PP can help predict the 
progression of SCI. Third, since widened PP is suggestive of diffuse atherosclerosis, 
therapeutic options aimed at reducing PP and limiting the progression of 
atherosclerosis would be important in attenuating the risk of SCI in addition to 
lowering the risk of cardiovascular diseases. 
Although it is still too early to call for modification to the current treatment 
recommendations for hypertension based on our single study, and further studies are 
obviously needed to determine the optimal range of PP for people of different age 
groups, our study might be helpful in developing new directions for the prevention of 
dementia. In addition, our results suggest that the potential confounding effect of PP 
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should be taken into account when examining the role of vascular risk factors in 
cognitive impairment in future studies. 
 In conclusion, although our present study did not find any evidence to show that 
hypertension was associated with development of SCI in the Chinese older people, 
further studies may help ascertain if there is indeed no association between 
hypertension and SCI in the local older population. In addition, our study showed that 
widened PP might be a risk factor for SCI among the younger old people, whereas age 
remained to be a major predictor of SCI among the older old people. More studies are 
needed to determine the role of PP in contributing to late-life cognitive impairment 
and the target BP for a cognitively beneficial effect in the older population. 
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Figures and Tables 
 
146 were excluded:
• 74 had CVA
• 49 had significant cognitive impairment
• 13 lived in OAH
• 3 were non‐Chinese
• 5 had significant cognitive impairment and CVA
• 1 had significant cognitive impairment and lived in OAH
• 1 was non‐Chinese with significant cognitive impairment 
2071 attended EHC in 2005
1925 were recruited
1453 had ≥2 annual assessments since 2006, 
with ≥ 1 assessment since 2008
472 had ≤2 annual assessments since 2006 
or defaulted follow‐up since 2008
143 were 
registered dead
329 were actively traced
168 did not have interview:
• 5 were reported to be dead
• 68 could not be traced
• 95 were traced but 
declined for interview
159 were interviewed:
• 101 were interviewed at EHC 
• 38 were interviewed at home
• 20 were interviewed by phone
2 attended EHC for assessment
 
Figure 1. Flowchart showing how the subjects were included in this study.  
EHC, Elderly Health Centre; CVA, Cerebrovascular Accidents; OAH, Old-aged Homes. 
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Table 1. Comparison of baseline characteristics between subjects who had regular 
follow-up in Elderly Health Centres (EHCs) and those who defaulted follow-up in the 
6-year study period. 
  Subjects with 
regular follow-up
(n=1453) 
Subjects who 
defaulted follow-up 
(n=472) 
Statistics 
(p-value) 
Median age, years 73 75 <0.001b
Female, n (%) 913 (62.8) 292 (61.9) 0.71a
Illiterate, n (%) 347 (23.9) 123 (26.1) 0.34a
Hypertension, n (%) 903 (62.1) 336 (71.2) <0.001a
Median SBP, mmHg 138 140 0.06b
Median DBP, mmHg 72 73 0.85b
Median PP, mmHg 66 68 0.06b
DM, n (%) 156 (10.7) 61 (12.9) 0.19a
Median HbA1c 7.0 7.0 0.72b
Hypercholesterolemia, n (%) 630 (43.4) 147 (31.1) <0.001a
Median fasting total 
cholesterol level, mmol/L 
5.4 5.3 0.01b
Heart disease, n (%) 116 (8.0) 69 (14.6) <0.001a
Median BMI, kg/m2 23.6 23.3 0.01b
Daily smoking, n (%) 70 (4.8) 30 (6.4) 0.19a
Weekly alcohol use, n (%) 61 (4.2) 13 (2.8) 0.16a
Depression, n (%) 53 (3.6) 25 (5.3) 0.11a
aχ2 test; bMann-Whitney U-test 
SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; PP, Pulse Pressure; DM, 
Diabetes Mellitus; BMI, Body Mass Index 
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Table 2. Age distribution among subjects who developed significant cognitive 
impairment in the 6-year study period. 
Number of subjects with incident 
significant cognitive impairment 
 
Male Female 
Percentage of subjects 
with incident significant 
cognitive impairment in 
each age group 
65-69 7 10 5.1 
70-74 17 34 6.5 
75-79 14 37 9.5 
80-84 12 17 14.4 
Age 
group 
≥85 4 9 20.6 
Total 54 107  
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Table 3. Comparison of baseline characteristics between subjects who remained 
cognitively stable and those who developed significant cognitive impairment in 6 
years. 
  Cognitively 
stable 
(n=1764) 
Significant cognitive 
impairment 
(n=161) 
Statistics 
(p-value) 
Median age, years 73 75 <0.001b
Female, n (%) 1098 (62.2) 107 (66.5) 0.29a
Illiterate, n (%) 421 (23.9) 49 (30.4) 0.06a
Hypertension, n (%) 1133 (64.2) 106 (65.8) 0.68a
Median SBP, mmHg 138 140 0.10b
Median DBP, mmHg 72 72 0.50b
Median PP, mmHg 66 70 0.03b
DM, n (%) 194 (11.0) 23 (14.3) 0.21a
Median HbA1c 7.0 7.2 0.53b
Hypercholesterolemia, n (%) 706 (40.0) 71 (44.1) 0.31a
Median fasting total 
cholesterol level, mmol/L 
5.4 5.5 0.79b
Heart disease, n (%) 168 (9.5) 17 (10.6) 0.67a
Median BMI, kg/m2 23.5 23.1 0.14b
Daily smoking, n (%) 92 (5.2) 8 (5.0) 0.89a
Weekly alcohol use, n (%) 67 (3.8) 7 (4.3) 0.73a
Depression, n (%) 69 (3.9) 9 (5.6) 0.30a
aχ2 test; bMann-Whitney U-test 
SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; PP, Pulse Pressure; DM, 
Diabetes Mellitus; BMI, Body Mass Index 
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Table 4. Effect of pulse pressure on significant cognitive impairment of all ages using 
multiple logistic regression analysis. 
 Odds Ratio 
(95% confidence interval) 
p-value 
Age 1.07 (1.04–1.11) <0.001 
Illiteracy 0.82 (0.57–1.17) 0.27 
SBP 0.99 (0.98–1.01) 0.36 
PP 1.02 (0.99–1.04) 0.12 
SBP, Systolic Blood Pressure; PP, Pulse Pressure 
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Table 5. Effect of pulse pressure on significant cognitive impairment in different age 
groups using multiple logistic regression analysis. 
 Odds Ratio 
(95% confidence interval) 
p-value 
(A) Age ≥70 years old 
Age 1.47 (0.91–2.37) 0.12 
Illiteracy 0.78 (0.54–1.11) 0.17 
SBP 0.99 (0.97–1.01) 0.22 
PP 1.02 (1.00–1.05) 0.03 
(B) Age ≥75 years old 
Age  1.89 (1.35–2.65) <0.001 
Illiteracy 0.80 (0.56–1.14) 0.22 
SBP 0.99 (0.98–1.01) 0.33 
PP 1.02 (0.99–1.04) 0.08 
(C) Age ≥80 years old 
Age  2.19 (1.48–3.23) <0.001 
Illiteracy 0.77 (0.54–1.10) 0.15 
SBP 0.99 (0.97–1.01) 0.29 
PP 1.02 (0.99–1.04) 0.07 
SBP, Systolic Blood Pressure; PP, Pulse Pressure 
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Table 6. Comparison of the longitudinal readings of pulse pressure over the 6-year 
study period between subjects who remained cognitively stable and those who 
developed significant cognitive impairment.  
p-valuea
Year 
Median PP,  
mmHg 2005 versus 2008 2008 versus 2011 2005 versus 2011 
Subjects who remained cognitively stable: 
2005 64.5  
2008 68.0 
<0.001 
2011 70.0  
0.03 
 
<0.001 
Subjects who developed significant cognitive impairment: 
2005 74.0  
2008 70.0 
0.48 
2011 69.0  
0.92 
 
0.39 
aWilcoxon test 
PP, Pulse Pressure 
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